Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FVYA9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,747
Award facts
- Contract value 100% obligated
- $51,747.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $51,747.10 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on December 22, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price contract, which carries no set-aside designation, is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 vehicle that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains extensive federal contract relationships with the Defense Logistics Agency for medical supply chain support. The company's contract portfolio demonstrates capability across diverse pharmaceutical categories including specialty medications, vaccines, and medical devices, with deliveries supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dupixent, an immunosuppressant therapy primarily indicated for eczema, asthma, and other inflammatory conditions, is among the specialized pharmaceutical products the contractor supplies through its federal vehicle to support military medical readiness and veteran healthcare initiatives.
Quick answers
Who was awarded contract SPE2DR26FVYA9?
SPE2DR26FVYA9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FVYA9 worth?
The government has obligated $51,747 on SPE2DR26FVYA9.
Is contract SPE2DR26FVYA9 an order under another contract?
Yes. SPE2DR26FVYA9 is a delivery order under SPE2DR25D3002, an indefinite delivery contract.
Was contract SPE2DR26FVYA9 competed?
The extent of competition for SPE2DR26FVYA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award